Nuveen’s Array Biopharma Inc ARRY Stock Holding History

Nuveen’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,993,194	Closed	-$92.3M	–	3282
2019 Q2	$92.3M	Buy	1,993,194 +1,943,218	+3,888%	+$54.6M	0.04%	453
2019 Q1	$1.22M	Buy	+49,976	New	+$1.04M	0.01%	713
2017 Q1	–	Sell	-10,471	Closed	-$92K	–	1536
2016 Q4	$92K	Buy	+10,471	New	+$77K	﹤0.01%	1481
2016 Q1	–	Sell	-10,029	Closed	-$42	–	1531
2015 Q4	$42	Sell	10,029 -405	-4%	-$1.85K	﹤0.01%	1486
2015 Q3	$48	Hold	10,434	–	–	﹤0.01%	1519
2015 Q2	$75	Sell	10,434 -368	-3%	-$2.72K	﹤0.01%	1559
2015 Q1	$80K	Buy	+10,802	New	+$76.9K	﹤0.01%	1549
2014 Q4	–	Sell	-10,287	Closed	-$37K	–	1688
2014 Q3	$37K	Hold	10,287	–	–	﹤0.01%	1567
2014 Q2	$47K	Hold	10,287	–	–	﹤0.01%	1575
2014 Q1	$48K	Hold	10,287	–	–	﹤0.01%	1566
2013 Q4	$52K	Buy	+10,287	New	+$56K	﹤0.01%	1547

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Nuveen's ARRY Position: Q3 2019 in Review

Nuveen sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,993,194 shares — an estimated $92.3M sold.

Nuveen first reported a position in ARRY in Q4 2013 and held it in 11 quarters. The position peaked at $92.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Nuveen reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Nuveen sold 1,993,194 Array Biopharma Inc shares in Q3 2019, an estimated $92.3M.
Nuveen first reported a position in Array Biopharma Inc in Q4 2013 and held it in 11 quarters.
Nuveen's Array Biopharma Inc position peaked at $92.3M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Nuveen's 13F filing for Q3 2019, filed 14 Nov 2019.